Global Enoxaparin API Market Growth 2023-2029

Global Enoxaparin API Market Growth 2023-2029

Enoxaparin is made from heparin and is one type of the low molecular weight heparin (LMWH). It is used as an anticoagulant that prevents the formation of blood clots also known as ‘blood thinner’. It is used to treat various conditions including deep vein thrombosis (DVT), pulmonary embolism in the lungs, acute coronary syndrome and heart attack.
LPI (LP Information)' newest research report, the “Enoxaparin API Industry Forecast” looks at past sales and reviews total world Enoxaparin API sales in 2022, providing a comprehensive analysis by region and market sector of projected Enoxaparin API sales for 2023 through 2029. With Enoxaparin API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Enoxaparin API industry.
This Insight Report provides a comprehensive analysis of the global Enoxaparin API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Enoxaparin API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Enoxaparin API market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Enoxaparin API and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Enoxaparin API.
The global Enoxaparin API market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Enoxaparin API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Enoxaparin API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Enoxaparin API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Enoxaparin API players cover Pfizer Inc., Sanofi S.A., GlaxoSmithKline Plc, Bristol Myer Squibb Company, Bohehringer Ingelheim, Eisai Inc., Teva Pharmaceutical Industries Ltd., Abbot India Limited, Novartis AG and ChemWerth, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Enoxaparin API market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Multi Vials
Pre-Filled Syringes
Others
Segmentation by application
COVID-19
Pulmonary Embolism
Atrial Fibrillation
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Pfizer Inc.
Sanofi S.A.
GlaxoSmithKline Plc
Bristol Myer Squibb Company
Bohehringer Ingelheim
Eisai Inc.
Teva Pharmaceutical Industries Ltd.
Abbot India Limited, Novartis AG
ChemWerth
Laboratorios Farmaceuticos ROVI SA
Gland Pharma Limited
Hanways Chempharma Co. Ltd
Changzhou Qianhong Biopharma
Shenzhen Hepalink Pharmaceutical Group
Key Questions Addressed in this Report
What is the 10-year outlook for the global Enoxaparin API market?
What factors are driving Enoxaparin API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Enoxaparin API market opportunities vary by end market size?
How does Enoxaparin API break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.